Mitesh

Class 4 Medicines Defect Information: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) Drug alert number: EL (24)A/01 Date issued: 04 January 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) Company name: Quadrant Pharmaceuticals Ltd Product name: Cozaar® [...]

The post Class 4 Medicines Defect Information: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) appeared first on Community Pharmacy England.

The 3rd price concession update published below on 22 December 2023 is the final update for the month. There are no further price concessions to announce for the month of December. However, Community Pharmacy England has queried some of prices imposed by DHSC and we are currently awaiting their response. If granted, any price adjustments [...]

The post December 2023 Price Concessions 3rd and Final Update appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/12/2023) announced the following list of price concessions for December 2023. Community Pharmacy England has received a large number of reports of products not available at their Drug [...]

The post December 2023 Price Concessions 2nd Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Glucagon (GlucaGen®) 1mg powder for injection kit . MSN/2023/051 Tier 2 – medium impact Date of issue 18th December 2023 There are two licensed glucagon preparations: GlucaGen® (1mg powder for injection kit) and Ogluo® (0.5mg and 1mg pre-filled auto-injector pens) There [...]

The post Medicine Supply Notification: Glucagon (GlucaGen®) 1mg powder for injection kit appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets. MSN/2023/116 Tier 2 – medium impact Date of issue 18th December 2023 Oxybutynin 5mg modified-release tablets are out of stock until early April 2024. Oxybutynin immediate release formulations (tablets and liquid) remain available and can support increased [...]

The post Medicine Supply Notification: Oxybutynin 5mg modified-release tablets appeared first on Community Pharmacy England.